Contribution of immunohistochemical (IHC) markers to the diagnosis of pulmonary carcinoids Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Cytology in differential diagnosis of histological types of NSCLC Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
MAdL: A new diagnostic marker for adenocarcinomas Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Potential prognostic factors in typical and atypical carcinoid tumours of the lung - immunhistochemical investigations Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001
Biodynamic approach to pretreatment level of tumor marker CYFRA 21-1 in differential diagnosis of single pulmonary nodules Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003
Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma Source: Eur Respir J 2013; 41: 943-951 Year: 2013
Detection of aberrant methylation of p16(INK4a) and MGMT in endobronchial specimens increases the diagnostic yield in cases of suspected peripheral lung carcinomas Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002
Clinicopathologic features, histologic and immunohistochemical characteristics, and clinical outcome of patients with cardiac myofibroblastic tumors Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 81s Year: 2006
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
The differential diagnosis of pulmonary pre-invasive lesions Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=37 Year: 2007
Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Source: Eur Respir J 2004; 24: 24-29 Year: 2004
Diagnostic value of Ki-67 and repp 86 in distinction between benign and malignant mesothelial proliferations Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
The role of EBUS-TBNA in genetic phenotype determination at adenocarcinoma cases Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018